No surprise about the pharmaceutical influence over prescribing practices:
At a recent speech before another society, the American College of Cardiology, its new president, Dr. Steven E. Nissen of the Cleveland Clinic, suggested that the medical profession had become addicted to industry money just as the nation was addicted to foreign oil.
There really should be no reason to treat hypertension with any brand-name drugs. The exception is the need for a angiotensin-receptor blocker (ARB), which does not have a generic yet.
